Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;44(1):26-34.
doi: 10.1016/j.jbi.2010.02.003. Epub 2010 Feb 10.

Towards an ontological theory of substance intolerance and hypersensitivity

William R Hogan  1
Affiliations

Towards an ontological theory of substance intolerance and hypersensitivity

William R Hogan. J Biomed Inform. 2011 Feb.

Abstract

A proper ontological treatment of intolerance--including hypersensitivity--to various substances is critical to patient care and research. However, existing methods and standards for documenting these conditions have flaws that inhibit these goals, especially translational research that bridges the two activities. In response, I outline a realist approach to the ontology of substance intolerance, including hypersensitivity conditions. I defend a view of these conditions as a subtype of disease. Specifically, a substance intolerance is a disease whose pathological process(es) are realized upon exposure to a quantity of substance of a particular type, and this quantity would normally not cause the realization of the pathological process(es). To develop this theory, it was necessary to build pieces of a theory of pathological processes. Overall, however, the framework of the Ontology for General Medical Science (which uses Basic Formal Ontology as its uppermost level) was a more-than-adequate foundation on which to build the theory.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The hierarchy from BFO down to substance intolerance disease and its subtypes.
Figure 2
Figure 2
The pathological process hierarchy.
See this image and copyright information in PMC

References

    1. Saxon A, Diaz-Sanchez D, Zhang K. The allergic response in host defense. In: Rich R, Fleisher T, Shearer W, Kotzin B, Schroeder H, editors. Clinical immunology: Principles and practice. 2nd ed. Mosby; London: 2001.
    1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009 Feb;32(2):287–94. - PMC - PubMed
    1. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005 Aug;5(4):309–16. - PubMed
    1. Ceusters W, Capolupo M, DeMoor G, Devlies J. Introducing realist ontology for the representation of adverse events; Proceedings of FOIS; IOS Press. 2008.
    1. Bates B, Hoekelman R. Interviewing and the health history. In: Bates B, editor. A guide to physical examination. Third ed. JB Lippincott Company; Philadelphia: 1983.

Publication types

MeSH terms